Bahl & Gaynor Inc Omnicell, Inc Transaction History

Bahl & Gaynor Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$68.36 - $88.34 $1.85 Million - $2.4 Million	-27,122 Closed	0 $0
Q2 2019 Aug 12, 2019	SELL	$71.38 - $92.21 $1.1 Million - $1.41 Million	-15,343 Reduced 36.13%	27,122 $2.33 Million
Q1 2019 May 13, 2019	BUY	$58.88 - $86.19 $61,411 - $89,896	1,043 Added 2.52%	42,465 $3.43 Million
Q4 2018 Feb 12, 2019	SELL	$56.97 - $77.23 $181,506 - $246,054	-3,186 Reduced 7.14%	41,422 $2.54 Million
Q3 2018 Nov 09, 2018	BUY	$52.65 - $71.9 $55,019 - $75,135	1,045 Added 2.4%	44,608 $3.21 Million
Q2 2018 Aug 14, 2018	SELL	$42.2 - $53.05 $2.17 Million - $2.72 Million	-51,312 Closed	0 $0
Q1 2018 May 11, 2018	SELL	$40.1 - $52.45 $575,555 - $752,814	-14,353 Reduced 21.86%	51,312 $2.23 Million
Q4 2017 Feb 13, 2018	BUY	$45.3 - $54.5 $37,372 - $44,962	825 Added 1.27%	65,665 $3.19 Million
Q3 2017 Nov 13, 2017	BUY	$48.1 - $52.15 $495,189 - $536,884	10,295 Added 18.87%	64,840 $3.31 Million
Q2 2017 Aug 11, 2017	BUY	N/A	9,890 Added 22.15%	54,545 $2.35 Million
Q2 2017 Aug 10, 2017	BUY	N/A	44,655	44,655 $1.51 Million

277

44.6M

224K

35.7K

Ticker OMCL
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 44,288,800
Market Cap $1.94B
Description
Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensi...

Get notified when there are updates to the investment portfolio of Bahl & Gaynor Inc, based on Form 13F filings with the SEC.

Stay updated on Bahl & Gaynor Inc with notifications on news.